{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:27:59Z","timestamp":1792481279318,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ultrasound"],"DOI":"10.1007\/s40477-023-00843-y","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T16:02:36Z","timestamp":1705420956000},"page":"323-329","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal assessment of liver stiffness using ARFI technique does not support increased risk of fibrosis in rheumatoid arthritis patients on methotrexate"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6600-3691","authenticated-orcid":false,"given":"Arne","family":"Sch\u00e4fer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9215-6501","authenticated-orcid":false,"given":"Magdolna Szilvia","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6154-4322","authenticated-orcid":false,"given":"Anna","family":"Eder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5805-806X","authenticated-orcid":false,"given":"Axel","family":"Nigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8028-8099","authenticated-orcid":false,"given":"Martin","family":"Feuchtenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"key":"843_CR1","first-page":"1","volume":"5","author":"MD Skinner","year":"1974","unstructured":"Skinner MD, Schwartz RS (1974) Immunosuppressive therapy of immunoinflammatory diseases. Rheumatology 5:1\u201348","journal-title":"Rheumatology"},{"key":"843_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","volume":"82","author":"JS Smolen","year":"2023","unstructured":"Smolen JS, Landewe RBM, Bergstra SA, Kerschbaumer A, Sepriano A, Aletaha D, Caporali R, Edwards CJ, Hyrich KL, Pope JE, De Souza S, Stamm TA, Takeuchi T, Verschueren P, Winthrop KL, Balsa A, Bathon JM, Buch MH, Burmester GR, Buttgereit F, Cardiel MH, Chatzidionysiou K, Codreanu C, Cutolo M, Den Broeder AA, El Aoufy K, Finckh A, Fonseca JE, Gottenberg JE, Haavardsholm EA, Iagnocco A, Lauper K, Li Z, Mcinnes IB, Mysler EF, Nash P, Poor G, Ristic GG, Rivellese F, Rubbert-Roth A, Schulze-Koops H, Stoilov N, Strangfeld A, Van Der Helm-Van MA, Van Duuren E, Vliet Vlieland TPM, Westhovens R, Van Der Heijde D (2023) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis 82:3\u201318. https:\/\/doi.org\/10.1136\/ard-2022-223356","journal-title":"Ann Rheum Dis"},{"key":"843_CR3","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/acr.24596","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, Carandang K, Deane KD, Genovese M, Huston KK, Kerr G, Kremer J, Nakamura MC, Russell LA, Singh JA, Smith BJ, Sparks JA, Venkatachalam S, Weinblatt ME, Al-Gibbawi M, Baker JF, Barbour KE, Barton JL, Cappelli L, Chamseddine F, George M, Johnson SR, Kahale L, Karam BS, Khamis AM, Navarro-Millan I, Mirza R, Schwab P, Singh N, Turgunbaev M, Turner AS, Yaacoub S, Akl EA (2021) 2021 American College of rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 73:924\u2013939. https:\/\/doi.org\/10.1002\/acr.24596","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"843_CR4","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1001\/archderm.1970.04000120031005","volume":"102","author":"GD Weinstein","year":"1970","unstructured":"Weinstein GD, Cox JW, Suringa DW, Millard MM, Kalser M, Frost P (1970) Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis. Arch Dermatol 102:613\u2013618","journal-title":"Arch Dermatol"},{"key":"843_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1001\/archderm.1971.04000150020003","volume":"103","author":"HH Roenigk Jr","year":"1971","unstructured":"Roenigk HH Jr, Bergfeld WF, St Jacques R, Owens FJ, Hawk WA (1971) Hepatotoxicity of methotrexate in the treatment of psoriasis. Arch Dermatol 103:250\u2013261","journal-title":"Arch Dermatol"},{"key":"843_CR6","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/art.1780290702","volume":"29","author":"JM Kremer","year":"1986","unstructured":"Kremer JM, Lee JK (1986) The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 29:822\u2013831. https:\/\/doi.org\/10.1002\/art.1780290702","journal-title":"Arthritis Rheum"},{"key":"843_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/BF01308193","volume":"30","author":"SB Lanse","year":"1985","unstructured":"Lanse SB, Arnold GL, Gowans JD, Kaplan MM (1985) Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritis. An acceptable risk\/benefit ratio. Dig Dis Sci 30:104\u2013109. https:\/\/doi.org\/10.1007\/BF01308193","journal-title":"Dig Dis Sci"},{"key":"843_CR8","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1002\/art.11276","volume":"48","author":"T Pincus","year":"2003","unstructured":"Pincus T (2003) Guidelines for monitoring of methotrexate therapy: \u201cevidence-based medicine\u201d outside of clinical trials. Arthritis Rheum 48:2706\u20132709. https:\/\/doi.org\/10.1002\/art.11276","journal-title":"Arthritis Rheum"},{"key":"843_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00393-018-0481-y","volume":"77","author":"C Fiehn","year":"2018","unstructured":"Fiehn C, Holle J, Iking-Konert C, Leipe J, Weseloh C, Frerix M, Alten R, Behrens F, Baerwald C, Braun J, Burkhardt H, Burmester G, Detert J, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Krause A, Kuipers J, Lorenz HM, Muller-Ladner U, Nothacker M, Nusslein H, Rubbert-Roth A, Schneider M, Schulze-Koops H, Seitz S, Sitter H, Specker C, Tony HP, Wassenberg S, Wollenhaupt J, Kruger K (2018) S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs. Z Rheumatol 77:35\u201353. https:\/\/doi.org\/10.1007\/s00393-018-0481-y","journal-title":"Z Rheumatol"},{"key":"843_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/bjd.14816","volume":"175","author":"RB Warren","year":"2016","unstructured":"Warren RB, Weatherhead SC, Smith CH, Exton LS, Mohd Mustapa MF, Kirby B, Yesudian PD (2016) British association of dermatologists\u2019 guidelines for the safe and effective prescribing of methotrexate for skin disease 2016. Br J Dermatol 175:23\u201344. https:\/\/doi.org\/10.1111\/bjd.14816","journal-title":"Br J Dermatol"},{"key":"843_CR11","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2165\/00128071-200506060-00003","volume":"6","author":"JA Thomas","year":"2005","unstructured":"Thomas JA, Aithal GP (2005) Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary? Am J Clin Dermatol 6:357\u2013363. https:\/\/doi.org\/10.2165\/00128071-200506060-00003","journal-title":"Am J Clin Dermatol"},{"key":"843_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/0002-9343(91)90667-M","volume":"90","author":"QE Whiting-O'keefe","year":"1991","unstructured":"Whiting-O\u2019keefe QE, Fye KH, Sack KD (1991) Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am J Med 90:711\u2013716","journal-title":"Am J Med"},{"key":"843_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/bjd.12941","volume":"171","author":"CM Maybury","year":"2014","unstructured":"Maybury CM, Jabbar-Lopez ZK, Wong T, Dhillon AP, Barker JN, Smith CH (2014) Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies. Br J Dermatol 171:17\u201329. https:\/\/doi.org\/10.1111\/bjd.12941","journal-title":"Br J Dermatol"},{"key":"843_CR14","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1136\/ard.2008.093690","volume":"68","author":"C Salliot","year":"2009","unstructured":"Salliot C, Van Der Heijde D (2009) Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 68:1100\u20131104. https:\/\/doi.org\/10.1136\/ard.2008.093690","journal-title":"Ann Rheum Dis"},{"key":"843_CR15","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jaad.2017.04.1133","volume":"77","author":"MJM Rodriguez-Zuniga","year":"2017","unstructured":"Rodriguez-Zuniga MJM, Garcia-Perdomo HA (2017) Systematic review and meta-analysis of the association between psoriasis and metabolic syndrome. J Am Acad Dermatol 77:657-666.e658. https:\/\/doi.org\/10.1016\/j.jaad.2017.04.1133","journal-title":"J Am Acad Dermatol"},{"key":"843_CR16","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.jaad.2021.02.019","volume":"84","author":"JM Gelfand","year":"2021","unstructured":"Gelfand JM, Wan J, Zhang H, Shin DB, Ogdie A, Syed MN, Egeberg A (2021) Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: a population-based study. J Am Acad Dermatol 84:1636\u20131643. https:\/\/doi.org\/10.1016\/j.jaad.2021.02.019","journal-title":"J Am Acad Dermatol"},{"key":"843_CR17","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jhep.2022.12.034","volume":"78","author":"E Atallah","year":"2023","unstructured":"Atallah E, Grove JI, Crooks C, Burden-Teh E, Abhishek A, Moreea S, Jordan KM, Ala A, Hutchinson D, Aspinall RJ, Murphy R, Aithal GP (2023) Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated. J Hepatol 78:989\u2013997. https:\/\/doi.org\/10.1016\/j.jhep.2022.12.034","journal-title":"J Hepatol"},{"key":"843_CR18","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","volume":"29","author":"L Sandrin","year":"2003","unstructured":"Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F, Beaugrand M, Palau R (2003) Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29:1705\u20131713. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2003.07.001","journal-title":"Ultrasound Med Biol"},{"key":"843_CR19","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","volume":"127","author":"WM Rosenberg","year":"2004","unstructured":"Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, Hubscher S, Roskams T, Pinzani M, Arthur MJ, European Liver Fibrosis G (2004) Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 127:1704\u20131713. https:\/\/doi.org\/10.1053\/j.gastro.2004.08.052","journal-title":"Gastroenterology"},{"key":"843_CR20","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1007\/s00330-013-2927-6","volume":"23","author":"J Nierhoff","year":"2013","unstructured":"Nierhoff J, Chavez Ortiz AA, Herrmann E, Zeuzem S, Friedrich-Rust M (2013) The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis. Eur Radiol 23:3040\u20133053. https:\/\/doi.org\/10.1007\/s00330-013-2927-6","journal-title":"Eur Radiol"},{"key":"843_CR21","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Menard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G (2010) 2010 Rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"key":"843_CR22","unstructured":"Spss (2008) SPSS for Windows Release 17.0. In Armonk, NY: IBM; 2008"},{"key":"843_CR23","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00296-021-04804-8","volume":"41","author":"M Feuchtenberger","year":"2021","unstructured":"Feuchtenberger M, Kraus L, Nigg A, Schulze-Koops H, Schafer A (2021) Methotrexate does not increase the risk of liver fibrosis in patients with rheumatoid arthritis: assessment by ultrasound elastography (ARFI-MetRA study). Rheumatol Int 41:1079\u20131087. https:\/\/doi.org\/10.1007\/s00296-021-04804-8","journal-title":"Rheumatol Int"},{"key":"843_CR24","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/art.1780361208","volume":"36","author":"DJ Bjorkman","year":"1993","unstructured":"Bjorkman DJ, Boschert M, Tolman KG, Clegg DO, Ward JR (1993) The effect of long-term methotrexate therapy on hepatic fibrosis in rheumatoid arthritis. Arthritis Rheum 36:1697\u20131701. https:\/\/doi.org\/10.1002\/art.1780361208","journal-title":"Arthritis Rheum"},{"key":"843_CR25","first-page":"229","volume":"19","author":"CA Phillips","year":"1992","unstructured":"Phillips CA, Cera PJ, Mangan TF, Newman ED (1992) Clinical liver disease in patients with rheumatoid arthritis taking methotrexate. J Rheumatol 19:229\u2013233","journal-title":"J Rheumatol"},{"key":"843_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/anr.1780320202","volume":"32","author":"JM Kremer","year":"1989","unstructured":"Kremer JM, Lee RG, Tolman KG (1989) Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy. A prospective study with baseline and sequential biopsy samples. Arthritis Rheum 32:121\u2013127. https:\/\/doi.org\/10.1002\/anr.1780320202","journal-title":"Arthritis Rheum"},{"key":"843_CR27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.23923","volume":"4","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Felix S, Jeffers T, Younossi E, Nader F, Pham H, Afendy A, Cable R, Racila A, Younoszai Z, Lam BP, Golabi P, Henry L, Stepanova M (2021) Performance of the enhanced liver fibrosis test to estimate advanced fibrosis among patients with nonalcoholic fatty liver disease. JAMA Netw Open 4:e2123923. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.23923","journal-title":"JAMA Netw Open"},{"key":"843_CR28","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.jhep.2010.04.043","volume":"53","author":"D Laharie","year":"2010","unstructured":"Laharie D, Seneschal J, Schaeverbeke T, Doutre MS, Longy-Boursier M, Pellegrin JL, Chabrun E, Villars S, Zerbib F, De Ledinghen V (2010) Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study. J Hepatol 53:1035\u20131040. https:\/\/doi.org\/10.1016\/j.jhep.2010.04.043","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"843_CR29","first-page":"A1","volume":"69","author":"L Turner","year":"2020","unstructured":"Turner L, Bland M, Millson C, Veysey M, Hutchinson J (2020) Methotrexate: an innocent bystander in the development of liver fibrosis, findings of the STrATIFY study. Gut 69(Suppl 1):A1\u2013A51","journal-title":"Gut"},{"key":"843_CR30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3899\/jrheum.211281","volume":"49","author":"S Darabian","year":"2022","unstructured":"Darabian S, Wade JP, Kur J, Wade SD, Sayre EC, Badii M (2022) Using FibroScan to assess for the development of liver fibrosis in patients with arthritis on methotrexate: a single-center experience. J Rheumatol 49:558\u2013565. https:\/\/doi.org\/10.3899\/jrheum.211281","journal-title":"J Rheumatol"},{"key":"843_CR31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.55563\/clinexprheumatol\/usddjr","volume":"40","author":"J Avouac","year":"2022","unstructured":"Avouac J, Degrave R, Vergneault H, Combier A, Wanono S, Boisson M, Frantz C, Allanore Y (2022) Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 Index. Clin Exp Rheumatol 40:150\u2013157. https:\/\/doi.org\/10.55563\/clinexprheumatol\/usddjr","journal-title":"Clin Exp Rheumatol"},{"key":"843_CR32","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.jhep.2007.01.024","volume":"46","author":"P Rosenberg","year":"2007","unstructured":"Rosenberg P, Urwitz H, Johannesson A, Ros AM, Lindholm J, Kinnman N, Hultcrantz R (2007) Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment. J Hepatol 46:1111\u20131118. https:\/\/doi.org\/10.1016\/j.jhep.2007.01.024","journal-title":"J Hepatol"},{"key":"843_CR33","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15203","volume":"35","author":"JHM Lee","year":"2022","unstructured":"Lee JHM, Loo CH, Tan WC, Lee CK, Jamil A, Khor YH (2022) Comparison of noninvasive screening tools for hepatic fibrosis, association with methotrexate cumulative dose, and risk factors in psoriasis patients. Dermatol Ther 35:e15203. https:\/\/doi.org\/10.1111\/dth.15203","journal-title":"Dermatol Ther"},{"key":"843_CR34","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.7863\/ultra.15.14.10035","volume":"34","author":"TY Kim","year":"2015","unstructured":"Kim TY, Kim JY, Sohn JH, Lee HS, Bang SY, Kim Y, Kim MY, Jeong WK (2015) Assessment of substantial liver fibrosis by real-time shear wave elastography in methotrexate-treated patients with rheumatoid arthritis. J Ultrasound Med 34:1621\u20131630. https:\/\/doi.org\/10.7863\/ultra.15.14.10035","journal-title":"J Ultrasound Med"},{"key":"843_CR35","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00296-021-05059-z","volume":"42","author":"M Frankowski","year":"2022","unstructured":"Frankowski M, Swierkot J, Gomulkiewicz M, Korman L, Skoczynska M, Starba A (2022) Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis. Rheumatol Int 42:631\u2013638. https:\/\/doi.org\/10.1007\/s00296-021-05059-z","journal-title":"Rheumatol Int"},{"key":"843_CR36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3109\/00365521.2011.647412","volume":"47","author":"A Barbero-Villares","year":"2012","unstructured":"Barbero-Villares A, Mendoza Jimenez-Ridruejo J, Taxonera C, Lopez-Sanroman A, Pajares R, Bermejo F, Perez-Calle JL, Mendoza JL, Algaba A, Moreno-Otero R, Mate J, Gisbert JP (2012) Evaluation of liver fibrosis by transient elastography (Fibroscan(R)) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial. Scand J Gastroenterol 47:575\u2013579. https:\/\/doi.org\/10.3109\/00365521.2011.647412","journal-title":"Scand J Gastroenterol"},{"key":"843_CR37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/1756-185X.13442","volume":"22","author":"R Lertnawapan","year":"2019","unstructured":"Lertnawapan R, Chonprasertsuk S, Siramolpiwat S (2019) Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate. Int J Rheum Dis 22:214\u2013221. https:\/\/doi.org\/10.1111\/1756-185X.13442","journal-title":"Int J Rheum Dis"},{"key":"843_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59061029","author":"R Lertnawapan","year":"2023","unstructured":"Lertnawapan R, Chonprasertsuk S, Siramolpiwat S, Jatuworapruk K (2023) Correlation between cumulative methotrexate dose, metabolic syndrome and hepatic fibrosis detected by FibroScan in rheumatoid arthritis patients. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina59061029","journal-title":"Medicina (Kaunas)"},{"key":"843_CR39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.semarthrit.2015.05.003","volume":"45","author":"R Conway","year":"2015","unstructured":"Conway R, Low C, Coughlan RJ, O\u2019donnell MJ, Carey JJ (2015) Risk of liver injury among methotrexate users: a meta-analysis of randomised controlled trials. Semin Arthritis Rheum 45:156\u2013162. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.05.003","journal-title":"Semin Arthritis Rheum"},{"key":"843_CR40","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/rheumatology\/kep023","volume":"48","author":"K Lindsay","year":"2009","unstructured":"Lindsay K, Fraser AD, Layton A, Goodfield M, Gruss H, Gough A (2009) Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy. Rheumatology (Oxford) 48:569\u2013572. https:\/\/doi.org\/10.1093\/rheumatology\/kep023","journal-title":"Rheumatology (Oxford)"},{"key":"843_CR41","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1007\/s10067-021-05678-8","volume":"40","author":"P Bafna","year":"2021","unstructured":"Bafna P, Sahoo RR, Hazarika K, Manoj M, Rungta S, Wakhlu A (2021) Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis. Clin Rheumatol 40:3605\u20133613. https:\/\/doi.org\/10.1007\/s10067-021-05678-8","journal-title":"Clin Rheumatol"},{"key":"843_CR42","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jbspin.2010.02.024","volume":"77","author":"SH Park","year":"2010","unstructured":"Park SH, Choe JY, Kim SK (2010) Assessment of liver fibrosis by transient elastography in rheumatoid arthritis patients treated with methotrexate. Jt Bone Spine 77:588\u2013592. https:\/\/doi.org\/10.1016\/j.jbspin.2010.02.024","journal-title":"Jt Bone Spine"},{"key":"843_CR43","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41575-023-00782-3","volume":"20","author":"RJ Andrade","year":"2023","unstructured":"Andrade RJ, Bjornsson ES (2023) Liver fibrosis with methotrexate - an overestimated risk? Nat Rev Gastroenterol Hepatol 20:347\u2013348. https:\/\/doi.org\/10.1038\/s41575-023-00782-3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"843_CR44","doi-asserted-by":"publisher","first-page":"R232","DOI":"10.1186\/ar4075","volume":"14","author":"SW Lee","year":"2012","unstructured":"Lee SW, Park HJ, Kim BK, Han KH, Lee SK, Kim SU, Park YB (2012) Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate. Arthritis Res Ther 14:R232. https:\/\/doi.org\/10.1186\/ar4075","journal-title":"Arthritis Res Ther"}],"container-title":["Journal of Ultrasound"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40477-023-00843-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40477-023-00843-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40477-023-00843-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T05:13:12Z","timestamp":1749273192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40477-023-00843-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["843"],"URL":"https:\/\/doi.org\/10.1007\/s40477-023-00843-y","relation":{},"ISSN":["1876-7931"],"issn-type":[{"value":"1876-7931","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"4 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Sch\u00e4fer reports personal fees from Amgen, AstraZeneca, Novo Nordisk Pharma GmbH, outside the submitted work. Dr. Kovacs has nothing to disclose. Dr. Eder has nothing to disclose. Dr. Nigg has nothing to disclose. Dr. Feuchtenberger reports personal fees from AbbVie, personal fees from Novartis, personal fees from Roche, and personal fees from UCB outside of the submitted work. All authors disclose financial or non-financial interests that are directly or indirectly related to the work submitted for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of the University of W\u00fcrzburg, W\u00fcrzburg, Germany, on 12 July 2018 (2\/18-me).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients provided written informed consent for blood analysis, study participation and publication of data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}